Amy C. Moore: 20 years of progress in research and treatment in NSCLC
Amy C. Moore, Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation, shared on LinkedIn:
“LUNGevity Foundation recently convened the global lung cancer community during ILCSC24. Don’t miss the incredible keynote presentation by Dr. Peters Solange, highlighting 20 years of progress in research and treatment since the discovery of EGFR’s association with NSCLC unleashed a new era of precision medicine in our efforts.
You can access ILCSC24 recordings through Dec 31 for FREE when you register.”
More posts featuring Amy C. Moore
Amy C. Moore is the Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation. She previously served as the Director of Science & Research at the Addario Lung Cancer Medical Institute (ALCMI). She has published peer-reviewed papers on virology, cancer, and biomarker testing in NSCLC. Dr. Moore is also an expert on COVID-19’s impact on lung cancer and serves on several advisory boards.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023